← Back to Search

Cognitive Reappraisal Training for Borderline Personality Disorder (BPD Trial)

N/A
Recruiting
Led By Harold Koenigsberg, MD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Must not have
Age > 55
Timeline
Screening 3 days
Treatment Varies
Follow Up 3 days
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test a new way of helping people with Borderline Personality Disorder (BPD) manage their emotions by teaching them to think differently about emotional events. This method, called cognitive reappraisal training, could improve their mental health and behavior.

Who is the study for?
This trial is for medically healthy adults with Borderline Personality Disorder who can provide informed consent. It's not open to individuals over 55 or those with Schizotypal Personality Disorder or Avoidant Personality Disorder, due to their distinct neural activity patterns.
What is being tested?
The study tests a new treatment approach called cognitive reappraisal training by distancing. This method could be used alone or alongside other treatments for BPD, aiming to improve emotional regulation and influence behavior.
What are the potential side effects?
Since this is a psychological training intervention rather than a drug, traditional physical side effects are not expected. However, participants may experience emotional discomfort when engaging in the exercises.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am older than 55.

Timeline

Screening ~ 3 days
Treatment ~ Varies
Follow Up ~3 days
This trial's timeline: 3 days for screening, Varies for treatment, and 3 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in PINES Network activity
Change in Zanarini Rating Scale for Borderline Personality (ZAN-BPD)
Secondary study objectives
Change in Affective Lability Scale total (ALS)
Change in Beck Depression Scale score (BDI)
Change in Difficulty in Emotion Regulation Scale Scores (DERS)
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive Reappraisal-by-Distancing (CRD)Experimental Treatment1 Intervention
Subjects will be coached to use cognitive reappraisal-by-distancing to downregulate their negative reactions to aversive emotional pictures usng practice pictures.
Group II: Control Downregulate Condition (CD)Active Control1 Intervention
Subjects will be coached to practice their customary emotion regulatory techniques in a treatment occurring twice a week for 6 weeks.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Borderline Personality Disorder (BPD) like Dialectical Behavior Therapy (DBT) and Schema-focused therapy work by modifying dysfunctional thinking patterns and behaviors. DBT focuses on managing suicidal behaviors, improving emotional regulation, and enhancing interpersonal effectiveness. Schema-focused therapy aims to reshape deep-seated maladaptive beliefs formed in early life. Cognitive Reappraisal Training, similar to these therapies, helps patients reframe negative thoughts and emotions, which is crucial for reducing emotional dysregulation and improving overall functioning in BPD patients.

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,739,887 Total Patients Enrolled
13 Trials studying Borderline Personality Disorder
2,003 Patients Enrolled for Borderline Personality Disorder
Icahn School of Medicine at Mount SinaiLead Sponsor
904 Previous Clinical Trials
541,880 Total Patients Enrolled
3 Trials studying Borderline Personality Disorder
209 Patients Enrolled for Borderline Personality Disorder
William Marsh Rice UniversityOTHER
47 Previous Clinical Trials
28,077 Total Patients Enrolled

Media Library

Cognitive Reappraisal by Distancing Clinical Trial Eligibility Overview. Trial Name: NCT04967222 — N/A
Borderline Personality Disorder Research Study Groups: Cognitive Reappraisal-by-Distancing (CRD), Control Downregulate Condition (CD)
Borderline Personality Disorder Clinical Trial 2023: Cognitive Reappraisal by Distancing Highlights & Side Effects. Trial Name: NCT04967222 — N/A
Cognitive Reappraisal by Distancing 2023 Treatment Timeline for Medical Study. Trial Name: NCT04967222 — N/A
Borderline Personality Disorder Patient Testimony for trial: Trial Name: NCT04967222 — N/A
~20 spots leftby Nov 2025